Shanghai Mianyi Biopharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Mianyi Biopharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL) (NCT07668960) | Shanghai Mianyi Biopharmaceutical Co., Ltd. | 2026-06-17 |
Track Shanghai Mianyi Biopharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.